undefined undefined undefined

Efficacy of lipid lowering therapy beyond statins to prevent cardiovascular events

Event: ESC Congress 2024

Topic: Lipids

Session: Lipid-lowering therapies: new findings

Access

Like

Hemoglobin A1c and long-term mortality in patients undergoing coronary angiography: the ECAD registry

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease- Diagnostic methods

Access

Like

Association of lipoprotein(a)-levels with all-cause mortality following percutaneous coronary intervention

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease - Epidemiology, prognosis, outcome 3

Access

Like

Very low high-density lipoprotein-cholesterol and long-term mortality

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids

Session: Risk Factors and Prevention ePosters

Access

Like

HbA1c, coronary atheroma progression and cardiovascular events

Event: ESC Congress 2021 - The Digital Experience

Topic: Biomarkers

Session: Risk Factors and Prevention ePosters

Access

Like

Longitudinal high-sensitivity C-reactive protein and long-term cardiovascular outcomes in optimally-treated patients with high-risk vascular disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Biomarkers

Session: Risk Factors and Prevention ePosters

Access

Like

Efficacy of lipid lowering therapy beyond statins to prevent cardiovascular events: A meta-analysis

Event: ESC Congress 2019

Topic: Prevention

Session: Challenges in contemporary management of coronary artery disease

Access

Like

Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease

Event: ESC Congress 2018

Topic: Drug therapy

Session: Preventive cardiology / Lipids

Access

Like

Incidence of coronary and cardiovascular events in subjects with zero coronary artery calcification by risk factor profile in the general population

Event: ESC Congress 2016

Topic: X-ray Computed Tomography (CT)

Session: Novel clinical implications of cardiac CT

Access

Like

undefined undefined undefined

Contributor content

Efficacy of lipid lowering therapy beyond statins to prevent cardiovascular events

Hemoglobin A1c and long-term mortality in patients undergoing coronary angiography: the ECAD registry

Association of lipoprotein(a)-levels with all-cause mortality following percutaneous coronary intervention

Very low high-density lipoprotein-cholesterol and long-term mortality

HbA1c, coronary atheroma progression and cardiovascular events

Longitudinal high-sensitivity C-reactive protein and long-term cardiovascular outcomes in optimally-treated patients with high-risk vascular disease

Efficacy of lipid lowering therapy beyond statins to prevent cardiovascular events: A meta-analysis

Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease

Incidence of coronary and cardiovascular events in subjects with zero coronary artery calcification by risk factor profile in the general population

ESC 365 is supported by